No Data
Express News | Tempus AI, Inc. Reports 15.1% Stake in Personalis Inc as of July 3, 2024-SEC Filing
Why Tempus AI (TEM) Stock Is Rising
Tempus AI Inc (NASDAQ:TEM) shares are trading higher by 7.45% to $35.82 during Tuesday's session after the company announced it was granted Advanced Diagnostic Laboratory Test (ADLT) status for its ne
Tempus AI Shares Are Trading Higher After the Company Announced It Was Granted Advanced Diagnostic Laboratory Test Status for Its Next-generation Sequencing Assay From the Centers for Medicare & Medicaid Services.
Tempus AI Shares Are Trading Higher After the Company Announced It Was Granted Advanced Diagnostic Laboratory Test Status for Its Next-generation Sequencing Assay From the Centers for Medicare & Medic
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for Its XT CDx Test
Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted Advanced Diagnostic Laboratory Test
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Tempus AI, Inc. (NASDAQ:TEM) shares jumped 30.43% after the company announced it received U.S. FDA 510(k) cle
Express News | Tempus AI Rises for Third Straight Session, Last up 7.3%